| BioNTech SE. (3/17/20). "Press Release: Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine". New York, NY & Mainz. |
2020-03-17 |
| Evonik Industries AG. (3/17/20). "Press Release: Evonik Achieves Major Biotech Breakthrough with a New Animal-free and Fermentation-based Collagen Platform". |
2020-03-17 |
| BioNTech SE. (3/16/20). "Press Release: BioNTech and Fosun Pharma Form COVID-19 Vaccine Strategic Alliance in China". Mainz & Shanghai. |
2020-03-16 |
| BioNTech SE. (3/16/20). "Press Release: BioNTech Reports Rapid Progress on COVID-19 Vaccine Program to Address Global Public Health Threat". Mainz. |
2020-03-16 |
| High-Tech Gründerfonds Management GmbH. (3/9/20). "Press Release: High-Tech Gründerfonds and Bayern Kapital Invest in Digital Cardiology Clinic iAtros". |
2020-03-09 |
| Merck KGaA. (3/2/20). "Press Release: Erbitux Approved for First-Line Use in China in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) [Not intended for UK-based media]". Darmstadt. |
2020-03-02 |
| Boehringer Ingelheim. (2/28/20). "Press Release: Boehringer Ingelheim Receives Positive CHMP Opinion for Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease". Ingelheim. |
2020-02-28 |
| Merck KGaA. (2/27/20). "Press Release: Merck and AMCM / EOS Cooperate in 3D Printing of Tablets". Darmstadt. |
2020-02-27 |
| Boehringer Ingelheim. (2/27/20). "Press Release: Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform". Ingelheim & San Diego, CA. |
2020-02-27 |
| Merck KGaA. (2/19/20). "Press Release: Merck Divests Allergopharma to Dermapharm Holding SE". Darmstadt. |
2020-02-19 |
| Bayer AG. (2/10/20). "Press Release: Bayer, Meiogenix Collaborate to Accelerate Agricultural Innovation Through the Development of Unique Technologies". Monheim & Paris. |
2020-02-10 |
| Qiagen N.V.. (2/3/20). "Press Release: Qiagen Launches FFPE and Liquid Biopsy PIK3CA Diagnostics in Europe to Enhance Precision Medicine in Advanced Breast Cancer". Germantown, MD & Hilden. |
2020-02-03 |
| Bayer AG. (1/31/20). "Press Release: Bayer Welcomes U.S. Environmental Protection Agency’s Reaffirmation that Glyphosate Is Safe to Use, Not Carcinogenic". Whippany, NJ. |
2020-01-31 |
| Miltenyi Biotec B.V. & Co. KG. (1/30/20). "Press Release: Miltenyi Biotec Introduces World’s First Operator-free GMP-Compliant Cell Sorting System". Bergisch Gladbach. |
2020-01-30 |
| Merck KGaA. (1/27/20). "Press Release: Merck Invests in State-Of-The-Art Biotech Development Facility in Switzerland". Corsier-sur-Vevey. |
2020-01-27 |
| HepaRegenix GmbH. (1/21/20). "Press Release: HepaRegenix GmbH Secures Series B Financing in Excess of €11 Mio. to Advance First Drug Candidate to the Clinic". Tübingen. |
2020-01-21 |
| BioNTech SE. (1/16/20). "Press Release: BioNTech to Acquire Neon to Strengthen Global Leadership Position in T Cell Therapies". Mainz & Cambridge, MA. |
2020-01-16 |
| Qiagen N.V.. (1/16/20). "Press Release: Qiagen Launches Oncology Molecular Profiling Services in Europe. Qiagen Clinical Insights (QCI) Fully Integrates N-of-One Product into Portfolio". Redwood City, CA & Hilden. |
2020-01-16 |
| BioNTech SE. (1/13/20). "Press Release: BioNTech Appoints Ryan Richardson as Chief Strategy Officer to Support its Continued Global Expansion". Mainz. |
2020-01-13 |
| Qiagen N.V.. (1/13/20). "Press Release: Qiagen Builds on Global Collaboration with Amgen for Companion Diagnostic Development in Non-small Cell Lung Cancer". Hilden & Germantown, MD. |
2020-01-13 |
| NBE Therapeutics AG. (1/10/20). "Press Release: NBE-Therapeutics Closes a USD 22M Series C Financing Round". Basel. |
2020-01-10 |
| Qiagen N.V.. (1/10/20). "Press Release: Qiagen Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony. Milestone Instrument Placed with Cenata GmbH in Germany". Hilden & Germantown, MD. |
2020-01-10 |
| ProteoMedix AG. (1/10/20). "Press Release: ProteoMedix Appoints Helge Lubenow as New CEO". Zürich-Schlieren. |
2020-01-10 |
| Boehringer Ingelheim. (1/9/20). "Press Release: Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases". Ingelheim & Singapore. |
2020-01-09 |
| Evotec SE. (1/9/20). "Press Release: Bayer and Evotec Form New Strategic Alliance Focusing on Polycystic Ovary Syndrome". Hamburg & Berlin. |
2020-01-09 |
| Eyevensys S.A.S.. (1/8/20). "Press Release: Eyevensys Closes $30M Series B Financing". Paris & Fort Worth, TX. |
2020-01-08 |
| Bayer AG. (1/7/20). "Press Release: Bayer Exercises Right to Enter into Follow-on Research and Collaboration Option Agreement with Atomwise. Companies to Continue Crop Protection Development Programs". Monheim & San Francisco, CA. |
2020-01-07 |
| genOway S.A.. (1/7/20). "Press Release: genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by Extending Their Partnership to All Animal Cell Models". Lyon. |
2020-01-07 |
| PhoreMost Ltd.. (1/7/20). "Press Release: PhoreMost and Boehringer Ingelheim Enter Multi-project Drug Discovery Collaboration". Cambridge. |
2020-01-07 |
| Merck KGaA. (12/19/19). "Press Release: Merck Licenses Foundational CRISPR Integration Technology to Promega". Darmstadt. |
2019-12-19 |
| Boehringer Ingelheim. (12/18/19). "Press Release: Boehringer Ingelheim Discontinues Development of BI 1467335 for NASH". Ingelheim & Sydney. |
2019-12-18 |
| Sidekick Health. (12/16/19). "Press Release: Sidekick Partners with Bayer to Provide Digital Therapy Expansion for PAD Patients". |
2019-12-16 |
| Boehringer Ingelheim. (12/13/19). "Press Release: Boehringer Ingelheim and Lilly Provide Update on Empagliflozin Phase III Exercise Ability Studies in Chronic Heart Failure". Ingelheim & Indianapolis, IN. |
2019-12-13 |
| Algiax Pharmaceuticals. (12/9/19). "Press Release: Algiax Is Ready to Go Into Proof-of-Concept for AP-325 and Welcomes New Investors". Düsseldorf. |
2019-12-09 |
| BC Platforms. (12/6/19). "Press Release: BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe". Zürich & Boston, MA. |
2019-12-06 |
| BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. |
2019-12-02 |
| Max-Delbrück-Centrum für Molekulare Medizin (MDC). (12/2/19). "Press Release: Deep Learning Identifies Molecular Patterns of Cancer". Berlin. |
2019-12-02 |
| Merck KGaA. (11/26/19). "Press Release: Japan and Singapore Grant CRISPR Patents to Merck". Darmstadt. |
2019-11-26 |
| BCNP Consultants GmbH. (11/25/19). "Press Release: World Café »Digitization of the Coating Industry« at the 4th European Chemistry Partnering on February 27, 2020". Frankfurt a. M.. |
2019-11-25 |
| Merck KGaA. (11/20/19). "Press Release: Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations 8Not intended for UK-based media]". Darmstadt. |
2019-11-20 |
| Merck KGaA. (11/12/19). "Press Release: Merck Licenses CRISPR Gene-Editing Technology to Evotec". Darmstadt. |
2019-11-12 |
| SciRhom GmbH. (11/5/19). "Press Release: SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases". Munich. |
2019-11-05 |
| Boehringer Ingelheim. (11/4/19). "Press Release: Boehringer Ingelheim and Lilly Modernise Alliance to Focus Full Expertise on Jardiance". Ingelheim & Indianapolis, IN. |
2019-11-04 |
| CEM Corporation. (10/29/19). "Press Release: CEM Corporation Acquires Key Assets of Intavis Bioanalytical Instruments". Matthews, NC. |
2019-10-29 |
| Boehringer Ingelheim. (10/29/19). "Press Release: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing". Ingelheim. |
2019-10-29 |
| Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. |
2019-10-28 |
| Biocat. (10/21/19). "Press Release: Boehringer Ingelheim Joins the d·HEALTH Barcelona Program to Foster Innovation in Health". Barcelona. |
2019-10-21 |
| Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. |
2019-10-15 |
| Merck KGaA. (10/10/19). "Press Release: Merck Becomes the First to Use Acoustic Technology for Cell Therapy Manufacturing". Darmstadt. |
2019-10-10 |
| Stilla Technologies S.A.S.. (10/10/19). "Press Release: Stilla Technologies Opens U.S. Subsidiary for Direct Commercial Operations Under the Leadership of Life Science Veteran". Beverly, MA. |
2019-10-10 |
| BioNTech SE. (10/10/19). "Press Release: BioNTech Announces Pricing of Initial Public Offering". Mainz. |
2019-10-10 |
| BCNP Consultants GmbH. (9/27/19). "Press Release: 2nd ECP Summer Summit at Henkel HQ, Düsseldorf". Düsseldorf & Frankfurt a. M.. |
2019-09-27 |
| BASF SE. (9/27/19). "Press Release: BASF’s Strategy in Agriculture Aims for Innovation-driven Growth in Specific Markets". |
2019-09-27 |
| T3 Pharmaceuticals AG. (9/26/19). "Press Release: Closing of Financing Round and Strengthening of Development Team Paves the Way for T3 Pharma to Enter the Clinic". |
2019-09-26 |
| Tacalyx GmbH. (9/25/19). "Press Release: Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment". Berlin. |
2019-09-25 |
| BioNTech SE. (9/24/19). "Press Release: BioNTech Announces Commencement of Initial Public Offering". Mainz. |
2019-09-24 |
| Boehringer Ingelheim. (9/20/19). "Press Release: Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases". Ingelheim & Newton, MA. |
2019-09-20 |
| High-Tech Gründerfonds Management GmbH. (9/16/19). "Press Release: Chemistry-for-Healthcare Start-up Secures Seed Investment from Investitionsbank Berlin (IBB) and High-Tech Gründerfonds (HTGF)". |
2019-09-16 |
| Max Planck Society. (9/12/19). "Press Release: Launch of Tech Transfer Fund KHAN-I". |
2019-09-12 |
| Max Planck Society. (9/11/19). "Press Release: Max Planck Society Grants License for New Drug Candidates". |
2019-09-11 |
| Grünenthal GmbH. (9/10/19). "Press Release: Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain". Aachen & Melbourne. |
2019-09-10 |
| ProBioGen AG. (9/10/19). "Press Release: ProBioGen Licenses GlymaxX Technology to Bayer". Berlin. |
2019-09-10 |
| Evonik Industries AG. (9/5/19). "Press Release: Evonik Invests in Chinese 3D-printing Start-up Making Medical Implants". Essen & Shanghai. |
2019-09-05 |
| BioNTech SE. (9/4/19). "Press Release: BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs". Mainz. |
2019-09-04 |
| Boehringer Ingelheim. (9/4/19). "Press Release: Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound". Ingelheim & Mumbai. |
2019-09-04 |
| Modag GmbH. (9/4/19). "Press Release: Modag Appoints Dr. Johannes Levin as Chief Medical Officer". Wendelsheim. |
2019-09-04 |
| Grünenthal GmbH. (9/3/19). "Press Release: Grünenthal and UniQuest Partner to Develop Novel Drug Candidates for Chronic Neuropathic Pain". Aachen & Brisbane. |
2019-09-03 |
| Evonik Industries AG. (9/3/19). "Press Release: Evonik Acquires a Surface Modification Technology Platform from Interface Biologics to Further Expand Its Medical Device Capabilities". |
2019-09-03 |
| Boehringer Ingelheim. (9/3/19). "Press Release: Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/Glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes". Ingelheim & Copenhagen. |
2019-09-03 |
| Bruker Corporation. (9/2/19). "Press Release: Bruker Launches Highest Resolution Large-Format Bio-AFM System". Münster. |
2019-09-02 |
| Eppendorf AG. (8/20/19). "Press Release: Eppendorf AG with Positive First Half-year 2019. Group Sales Grow by 12.8% Percent to €378.5 million". Hamburg. |
2019-08-20 |
| Grünenthal GmbH. (8/13/19). "Pressemitteilung: Einigung über Neuausrichtung der Forschungs- und Entwicklungsorganisation bei Grünenthal". Aachen. |
2019-08-13 |
| Nynomic AG. (8/12/19). "Press Release: Acquisition of the Business Operations of LemnaTec GmbH Strengthens Technological Competence in the Field of Plant Phenotyping". Wedel. |
2019-08-12 |
| Boehringer Ingelheim. (8/12/19). "Press Release: Boehringer Ingelheim and MD Anderson Form Unique Virtual Research and Development Center to Rapidly Advance New Cancer Therapies". Ingelheim. |
2019-08-12 |
| High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale". |
2019-08-08 |
| Merck KGaA. (8/6/19). "Press Release: Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab". Darmstadt. |
2019-08-06 |
| Sensyne Health plc. (7/31/19). "Press Release: Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease Using Clinical Artificial Intelligence". |
2019-07-31 |
| Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin. |
2019-07-31 |
| Evotec SE. (7/25/19). "Press Release: P2X3 Antagonist Demonstrates Efficacy against Refractory Chronic Cough in Phase II (POC)". Hamburg. |
2019-07-25 |
| Yumab GmbH. (7/22/19). "Press Release: Yumab Announces New Research and Collaboration Agreement with Merck". Braunschweig. |
2019-07-22 |
| Merck KGaA. (7/18/19). "Press Release: Intermolecular Stockholders Approve Acquisition by Merck". Darmstadt. |
2019-07-18 |
| Boehringer Ingelheim. (7/18/19). "Press Release: Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics". Ingelheim & Seongnam. |
2019-07-18 |
| Boehringer Ingelheim. (7/18/19). "Press Release: INMARK Results Suggest Prompt Treatment of IPF with Antifibrotics to Slow Disease Progression". Ingelheim. |
2019-07-18 |
| Evogene Ltd.. (7/16/19). "Press Release: Evogene Amends Its Collaboration Agreement with Bayer to Include Genome Editing Targets". Rehovot. |
2019-07-16 |
| Evotec SE. (7/15/19). "Press Release: Evotec Expands Its iPSC Platform. Acquired Assets from Ncardia AG". Hamburg. |
2019-07-15 |
| Boehringer Ingelheim. (7/15/19). "Press Release: Boehringer Ingelheim Acquires Amal Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform". Ingelheim & Geneva. |
2019-07-15 |
| Start Codon Ltd.. (7/10/19). "Press Release: Start Codon Strengthens Senior Team with Key Appointments". Cambridge. |
2019-07-10 |
| BioNTech SE. (7/9/19). "Press Release: BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline". Mainz. |
2019-07-09 |
| AiCuris Anti-infective Cures GmbH. (7/9/19). "Press Release: AiCuris and Lysando Join Forces in the Fight against Antimicrobial Resistance". Wuppertal & Balzers. |
2019-07-09 |
| SMS-Oncology (Specialized Medical Services-Oncology B.V.). (7/8/19). "Press Release: SMS-Oncology Opens New Office in Frankfurt, Germany". Schiphol. |
2019-07-08 |
| Mack Brooks Exhibitions Ltd.. (7/8/19). "Press Release: Trend Barometer Chemspec Europe 2019 Closes with Record in Visitor Numbers and Exhibition Space". |
2019-07-08 |
| High-Tech Gründerfonds Management GmbH. (7/3/19). "Press Release: “First-in-Class“ mRNA-therapeutics for Vascular Diseases – Pantherna Therapeutics Receives 7-digit Investment". |
2019-07-03 |
| Genedata AG. (7/2/19). "Press Release: Genedata and AB Enzymes Expand Partnership to Digitalize Strain Development". Basel. |
2019-07-02 |
| Bayer AG. (7/2/19). "Press Release: Leo Pharma Completes the Acquisition of Bayer’s Prescription Dermatology Business". Ballerup & Leverkusen. |
2019-07-02 |
| R-Biopharm AG. (7/1/19). "Press Release: Distribution of the New Innovative Molecular Diagnostics Platform Vivalytic Starts". Darmstadt. |
2019-07-01 |
| Merck KGaA. (7/1/19). "Press Release: Merck Places Bonds Amounting to € 2 Billion. Issuance Is Final Key Component in the Financing of the Planned Versum Transaction". Darmstadt. |
2019-07-01 |
| Boehringer Ingelheim. (7/1/19). "Press Release: Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline with New First-in-Class Compound from Yuhan Corporation". Ingelheim & Seoul. |
2019-07-01 |
| Modag GmbH. (6/27/19). "Press Release: Modag Launches Out of Stealth Mode with Series A Financing of EUR 12 Million to Develop Treatments for Parkinsonian Disorders, Including Multiple System Atrophy". Wendelsheim. |
2019-06-27 |
| Evotec SE. (6/26/19). "Press Release: Evotec SE Places First Schuldschein (Promissory Note) Worth EUR 250 m". Hamburg. |
2019-06-26 |
| Merck KGaA. (6/18/19). "Press Release: Merck Places Hybrid Bond Amounting to € 1.5 Billion. Placement Is an Important Part of the Financing of the Planned Acquisition of Versum Materials, Inc.". Darmstadt. |
2019-06-18 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
